Market Place
Sourcing Support
FDA approves Caris multi-cancer companion diagnostic test
13 Nov 2024 //
FIERCE BIOTECH
Merck KGaA signs $1.4B biobuck deal with Caris to expand ADC pipeline
05 Apr 2024 //
FIERCE BIOTECH
Caris Life Sciences, Incyte Partner to Advance Incyte`s Oncology Pipeline
07 Mar 2023 //
CONTRACT PHARMA
The Caris Welcomes The UCI Health Chao Family Comprehensive Cancer Center
31 Jan 2023 //
PR NEWSWIRE
Caris Life Sciences nears $2B in total funding with $400M haul
19 Jan 2023 //
FIERCE BIOTECH
Caris Life to Showcase Extensive Research with Leading Cancer Centers at ASCO
17 Jan 2023 //
PR NEWSWIRE
Juniper Biologics Partners With Caris For Molecular Profiling Distribution
11 Jan 2023 //
PR NEWSWIRE
Caris and Xencor Expand Target Discovery Collaboration for Novel XmAb Antibody
05 Jan 2023 //
PR NEWSWIRE
Caris Announces Expansion of Caris Discovery for Novel Precision Therapeutics
05 Jan 2023 //
PR NEWSWIRE
Caris Life Sciences and Hummingbird Bioscience Enter Strategic Collaboration
06 Dec 2022 //
CONTRACTPHARMA
Caris, Flatiron partner to vastly increase access to molecular testing available
26 Sep 2022 //
PHARMABIZ
BriaCell Partners with Caris Life Sciences to Expand Patient Outreach
14 Sep 2022 //
ISSUEDIRECT
Caris Life Sciences Announces Enhanced Epic Partnership to Improve Access
07 Jul 2022 //
PRNEWSWIRE
Caris Life Sciences Introduces the Caris Assure Liquid Biopsy Assay at ASCO 2022
03 Jun 2022 //
PRNEWSWIRE
New Research from Caris Precision Oncology Alliance Finds Prognostic and more
08 Apr 2022 //
PRNEWSWIRE
Pyramid Bio, Caris Collaborate for Trial in NTRK Fusion Solid Tumors
10 Mar 2022 //
PRNEWSWIRE
National Cancer Center Japan Joins Caris` Precision Oncology Alliance
10 Feb 2022 //
PRNEWSWIRE
Caris, HotSpot collaborate to advance precision medicine development
11 Jan 2022 //
PHARMABIZ
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.